Ghent biotech start-up myNEO is working on the development of a “universal vaccine” against Covid-19 using cancer treatment technology, she announced on Wednesday.
–
myNEO says it has identified peptides (pieces of protein) that can trigger a very targeted immune response. “By specifically choosing the fragments which are necessary for the functioning of the virus, the vaccine has a better effect against SARSCoV-2 (the virus responsible for Covid-19) and all other (future) forms of the same family of viruses containing these same parts “, underlines the Ghent biotech in a press release.
myNEO will now start pre-clinical trials. The objective is to carry out the first tests of the vaccine on humans in early 2021. It will be a vaccine targeting all common forms of Covid-19 as well as other viruses of the corona group such as SARS and MERS, aims for the start-up.
– .
